SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

Clinical trial NCT05846789 · RECRUITING

Trial details

NCT number: NCT05846789
Sponsor: Kathy Miller
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Triple Negative Breast Cancer Estrogen-receptor-low Breast Cancer

Start date: 2024-07-02
Primary completion: 2026-12-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.